8-K: Knowles Corporation Reports Strong Q3 2024 Results, Driven by Acquisition and Organic Growth

Knowles Corporation announced a 32% year-over-year revenue increase in Q3 2024, driven by the Cornell acquisition and organic growth, alongside the strategic divestiture of its Consumer MEMS Microphones business.

Summary

• Knowles Corporation reported a 32% increase in revenue from continuing operations in the third quarter of 2024, reaching $143 million, which was at the high end of their guided range.
• This growth was fueled by the acquisition of Cornell Dubilier and a 4% organic growth.
• Net cash from operations was $53 million, exceeding the high end of the guided range.
• Non-GAAP diluted earnings per share (EPS) from continuing operations was $0.26, at the midpoint of the guided range.
• The company signed a definitive agreement to sell its Consumer MEMS Microphones business, expected to close late in the fourth quarter of 2024.
• The Medtech & Specialty Audio segment saw a 10% year-over-year revenue increase, while the Precision Devices segment grew by 57% due to the Cornell acquisition.
• Knowles expects sequential revenue growth in both the Medtech & Specialty Audio and Precision Devices segments in the fourth quarter of 2024.
• The company's Q4 2024 revenue guidance is between $141 million and $151 million, with non-GAAP diluted EPS projected to be between $0.26 and $0.30.
• Net cash provided by operating activities for Q4 2024 is expected to be between $30 million and $40 million.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue growth, exceeding cash flow expectations, and a strategic divestiture to improve margins. While there are risks, the overall tone is optimistic and forward-looking.

Positives

• Revenue from continuing operations increased by 32% year-over-year, indicating strong growth.
• Net cash from operations exceeded expectations, demonstrating efficient cash management.
• The divestiture of the Consumer MEMS Microphones business is expected to improve the company's margin profile.
• Both the Medtech & Specialty Audio and Precision Devices segments showed revenue growth.
• The company is focusing on higher-value markets and products.
• The company expects continued revenue growth in the next quarter.
• Adjusted EBITDA margins improved in both MedTech & Specialty Audio and Precision Devices segments.

Negatives

• GAAP diluted earnings per share was $0.10, lower than the non-GAAP figure of $0.26 due to various adjustments.
• The company's Q3 2024 GAAP gross profit margin was 44.1%, down from 46.6% in Q3 2023.
• The sale of the Consumer MEMS Microphones business resulted in a loss from discontinued operations of $8.7 million in Q3 2024.
• Q4 2024 net cash provided by operating activities is expected to include $5 to $10 million of cash used by discontinued operations.

Risks

• The company faces risks related to the timing and execution of its restructuring program.
• There are risks associated with the settlement of supplier obligations and the cost of severance benefits.
• The company is exposed to risks related to global economic instability, including inflation and geopolitical uncertainties.
• There are risks associated with the company's dependence on a limited number of large customers.
• The company faces increasing competition and new entrants in the market.
• There are risks related to the company's reliance on third parties for manufacturing and assembly.
• The company is exposed to financial risks, including currency fluctuations and credit risks.
• A sustained decline in the stock price may result in the impairment of certain intangible or long-lived assets.

Future Outlook

The company expects Q4 2024 revenue to be between $141 million and $151 million, with non-GAAP diluted EPS between $0.26 and $0.30, and net cash provided by operating activities between $30 million and $40 million. They also anticipate sequential revenue growth in both the Medtech & Specialty Audio and Precision Devices segments.

Management Comments

• Jeffrey Niew, President and CEO of Knowles, stated that the company delivered revenues and cash provided by operating activities at or above the high end of their guided range.
• Mr. Niew also highlighted the higher margin profile of the remaining businesses after the divestiture of the Consumer MEMS Microphones business.
• Management believes that positioning themselves in segments with attractive growth prospects and defensible margins will drive sustainable cash flow growth and better returns to shareholders.

Industry Context

The company's strategic shift towards higher-margin markets like Medtech, Defense, Electrification, and Industrial aligns with the broader industry trend of focusing on specialized, high-value applications. The divestiture of the Consumer MEMS Microphones business reflects a move away from commoditized markets towards more profitable segments.

Comparison to Industry Standards

• Knowles' 32% year-over-year revenue growth in Q3 2024 is strong compared to many of its peers in the electronics components industry, though direct comparisons are difficult without specific competitor data.
• Companies like TDK and Murata, which also operate in the capacitor and RF filter space, have seen varying growth rates depending on their specific market focus and geographic exposure.
• The 57% growth in the Precision Devices segment due to the Cornell acquisition is a significant increase, suggesting a successful integration and market expansion strategy.
• The adjusted EBITDA margin of 24.6% is competitive, but further analysis would be needed to compare it to specific industry benchmarks and competitors like Analog Devices or Texas Instruments.
• The divestiture of the Consumer MEMS Microphones business is a strategic move to improve margins, which is a common strategy among companies seeking to optimize their portfolio and focus on higher-value segments.

Stakeholder Impact

• Shareholders are expected to benefit from the company's focus on higher-margin businesses and improved cash flow.
• Employees may experience changes due to the restructuring and divestiture, but the company's growth in other segments may create new opportunities.
• Customers in the Medtech, Defense, Electrification, and Industrial markets will benefit from the company's focus on high-performance solutions.
• Suppliers may see changes in demand due to the divestiture and the company's focus on specific segments.
• Creditors will likely view the improved cash flow and strategic focus positively.

Next Steps

• The company will complete the sale of the Consumer MEMS Microphones business by the end of Q4 2024.
• Knowles will continue to focus on growing its Medtech & Specialty Audio and Precision Devices segments.
• The company plans to host an Investor Forum in the first quarter of 2025.

Key Dates

Keywords

Knowles Corporation, financial results, Q3 2024, revenue growth, Medtech, Precision Devices, Cornell acquisition, divestiture, non-GAAP EPS, cash flow, microphones, audio, capacitors, RF filters